Julie Daves
Overview
Julie Daves received $533K in total compensation, including $307K in salary, at DiaMedica Therapeutics in 2023.
Source: SEC filing on April 4, 2024.
Related executives
We found five more executives who work or worked at DiaMedica Therapeutics.
Rick Pauls
DiaMedica Therapeutics
Chief Executive Officer
Scott Kellen
DiaMedica Therapeutics
Chief Financial Officer
Kirsten Gruis
DiaMedica Therapeutics
Chief Medical Officer
Harry Alcorn
DiaMedica Therapeutics
Senior Vice President of Clinical Operations
Todd Verdoorn
DiaMedica Therapeutics